AKR1B1 and Hyperglycemia: The new derivatives were tested for the ability to inhibit ALR2 and the most promising compound was evaluated also for the ability to protect cells from hyperglycaemia-induced oxidative stress by evaluating targets such as Sod1, Sod2 and Nrf2.